SCT Ceramics is a leading global supplier of brazed, ceramic-to-metal feedthroughs and casings for the active implantable medical device (AIMD) industry. Our clients’ end-products include pacemakers, defibrillators, cochlear implants and neurostimulation devices.
We emphasize collaborative client relationships in order to deliver the highest quality results and to guarantee performance, precision and reliability. Our in-house R&D and Design and Engineering teams deliver innovative solutions to modern problems such as miniaturization and RF transparency. From prototypes to series manufacturing, we provide integrated services that add value while minimizing cost and lead times.
TECHNICAL CERAMICS EXPERTISE
SCT Ceramics has over a century of experience in technical and advanced ceramics. Under the ALUCER® brand, we offer a range of high-purity, alumina formulas utilized across a variety of markets. Our biocompatible ceramic can be shaped to precision level requirements and is an ideal candidate for implantable packages due to its dielectric properties, corrosion resistance, biocompatibility and high mechanical strength.
In addition to aluminum oxide, we offer solutions in zirconia, sapphire or ruby. Custom materials can be developed to meet specific requirements.
THE BRAZING ADVANTAGE
The heart of our technological expertise lies in our mastery of ceramic-to-metal brazing. Our brazing technology produces an ultra-reliable hermetic seal, ideal for the most extreme and precious environments, such as the human body.
QUALITY ROOTED IN THE MEDICAL SECTOR
SCT Ceramics’ Medical Applications Division is devoted to developing and manufacturing implantable feedthroughs and casings for medical markets such as cardiac, cochlear and neurostimulation. All of our quality inspections and guarantees meet global medical market regulations. IQ, OQ and PQ phases are baked into our product development cycle and our Process Validation Plan makes use of validated flowcharts and quality documents in accordance with ISO 13485 standards. In addition, we use leading continuous improvements methods such as Six Sigma, 5S and Statistical Process Control (SPC).
Ceramic casings permits RF signals to pass through the device and allows for wireless power transfer, both requirements for modern implantable devices.
Brazed, ceramic-to-metal feedthroughs transfer electrical currents from the PCB or battery to their final destination. 100% of SCT Ceramics’ feedthroughs are tested for hermeticity and guarantee leak-free performance throughout the product’s lifespan. We are experts in miniaturization and provide ceramic solutions such as alumina, zirconia and ruby.
We work hand-in-hand with our clients to create designs entirely adapted to their unique devices. Our multidisciplinary teams put in place in place parameters that optimize cost, function, performance and quality assurance.
SCT Ceramics’ Medical Division is ISO 13485 certified and we ensure our products allow our clients to meet strict FDA, CE and NMPA (formerly CFDA) regulations and respond to ISO 10993 biocompatibility standards. IQ, OQ and PQ phases are baked into our overall process validation and leading continuous improvement methods such as Six Sigma, 5S and SPC guide our operations from idea to market.
SCT Ceramics’ accredited laboratory partners with other international research organizations to develop new materials and manufacturing methods in the ceramics industry.
We accompany our clients from CAD design to prototype to full mass production. Our development cycle is time-tested and designed to minimize risks and ensure a smooth transition from prototype to series.
Société des Céramiques Techniques (SCT CERAMICS) today announced a strategic license agreement with Heraeus Deutschland GmbH & Co. KG (HERAEUS). The long-term license grants rights to SCT Ceramics to manufacture and market implantable components and subassemblies, such as hermetic feedthoughs, using Heraeus’ CerMet IP. CerMet is an innovative technology which uses a bio-compatible material system made from aluminum oxide and platinum to achieve ultra-high density feedthroughs, while lowering production and procurement costs.